An Inevitable Allergy Collision: Asthma, Hay Fever, and COVID-19

While the spring and summer allergic burden escalates, patients’ immune and inflammatory pathways will be primed for hyper-reactivity as they are compounded by the additional challenges of the COVID-19 pandemic.

In this webinar, Dr. Chris D. Meletis, ND, shares research on COVID-19 as it pertains to airway, allergies, and sensitivities, and how identifying allergens and cross-reactivities can help patients better understand, and potentially minimize, their overall immune burden to support homeostasis during excess allostatic load.

We discuss the following literature topics:

• IgG Activation of Complement and Impact on Immune
• Food and Inhalant Cross-Reactivity
• Lung and Gut Microbiota in the Pathology of Asthma (2020 Scientific article)
• Efficacy of Glutathione Therapy in Relieving Dyspnea Associated with COVID-19 Pneumonia (2020 Scientific article)
• Childhood Allergies and Immunodeficiencies During Respiratory Virus Epidemics – The 2020 COVID-19 Pandemic (2020 Scientific article)
• Role of IgG, IgA, and IgE Inhalant Testing
• Supplements to Consider when Addressing Mitochondrion and Immune Homeostasis

Dr. Meletis shares his unique clinical insights into the role of controlling complement activation, the mitochondria, and even how the citric acid cycle plays a role in immune competence and reactivity.